Please enable JS



Most Recent



38 Patient Groups Speak Out Against Recent Ruling in Texas v. US

Dec 19/GHLF Staff / Meningitis

Ruling invalidates critical health care protections for millions of people with pre-existing conditions December 17, 2018 Categories: Advocacy News Washington, D.C., December, 17 2018 — Following Friday’s ruling in the case of Texas v. United States, which found all of the Affordable Care Act to be unconstitutional, 38 patient groups issued the following statement: “Our organizations, which collectively represent […]


Is It a Migraine or a Stroke? Getting It Wrong Happens in 18% of Cases, Says New Study

Dec 03/Barbara Brody / Migraine

It’s easy to mistake migraine with aura for stroke, especially when you don’t get migraine attacks regularly. When someone is having a stroke, time is of the essence. If it’s an ischemic stroke — the most common kind, which is caused by a clot blocking blood flow to the brain — you need a drug […]


Who Really Needs to Take CGRP Medication to Prevent Migraine? What New Guidelines Say

Nov 28/Barbara Brody / Migraine

These new medications are pricey, and insurers aren’t eager to cover them. New guidelines on which migraine patients need CGRPs most could help with access. If you frequently suffer from debilitating migraine attacks, you may already have a prescription for more than one type of medication: a pain-relieving drug to be taken when the pain […]


Global Healthy Living Foundation Launches Comprehensive Support Center to Navigate Health Insurance Decision-Making During Open-Enrollment

Oct 31/GHLF Staff / Press Releases

UPPER NYACK, N.Y.–(BUSINESS WIRE)–Global Healthy Living Foundation recently published A Patient’s Guide to Insurance Enrollmentto help people living with chronic disease understand and make decisions about their health insurance coverage options in time for the 2019 open enrollment season. “Patients shouldn’t need specialized education to understand insurance, but unfortunately, they do because of the complex structure […]


Global Healthy Living Foundation Urges Insurance Companies to Pass Savings to Patients Following Repatha (evolocumab) Price Reduction

Oct 24/GHLF Staff / Press Releases

UPPER NYACK, N.Y.–(BUSINESS WIRE)–Global Healthy Living Foundation asserts that health insurance companies are obligated to pass cost savings to patients resulting from the just-announced price reduction for Repatha (evolocumab, Amgen). Repatha is a treatmentin the PCSK9 inhibitor class for familial hypercholesterolemia (FH), an inherited disorder that can lead to aggressive and premature cardiovascular disease, and […]


Oops! We could not locate your form.